v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues [Abstract]    
Total revenue $ 111,585 $ 69,222
Operating expenses:    
Cost of sales 23,018 17,830
Research and development 46,044 32,222
Selling, general and administrative 57,706 45,638
Total operating expenses 126,768 95,690
Loss from operations (15,183) (26,468)
Other income (expense):    
Interest income 3,023 3,633
Interest expense (3,596) (3,577)
Other income, net 2,108 1,757
Net loss before provision for income taxes (13,648) (24,655)
Provision for income taxes 1,029 624
Net loss $ (14,677) $ (25,279)
Net loss per share, basic (in dollars per share) $ (0.30) $ (0.54)
Net loss per share, diluted (in dollars per share) $ (0.30) $ (0.54)
Weighted-average shares of common stock outstanding, basic (in shares) 48,889,058 46,927,550
Weighted-average shares of common stock outstanding, diluted (in shares) 48,889,058 46,927,550
Product sales, net    
Revenues [Abstract]    
Total revenue $ 111,585 $ 68,917
License and other revenue    
Revenues [Abstract]    
Total revenue $ 0 $ 305